Informational

Learn the basics of biosimilars, including what they are, how they are approved, and how they can help your patients.

See how biosimilars are evaluated based on the totality of evidence, including analytical, nonclinical, clinical pharmacology, PK/PD, and clinical studies.

Discover how comparative clinical studies play a supporting, rather than central, role in the approval of biosimilars.

Take a closer look at extrapolation to see how biosimilars may lead to faster approvals and potential benefits.

Find out the role that immunogenicity—the potential to elicit an immune response—plays in the approval of biosimilars.

A great resource to share with your patients. See how biosimilars are made and why they can make a difference.

Find out how biosimilars demonstrate equivalence in clinical trials.

Learn how the extrapolation process works for biosimilars.

Discover how real-world evidence supports the concept of extrapolation.

Discover how biosimilarity and extrapolation using the totality of evidence establishes a path for therapeutic monoclonal antibodies in oncology.

Discover more about the process of manufacturing biosimilars.

Learn about engaging P&T committees when placing a biosimilar on formulary.

Learn how to ensure effective implementation of a biosimilar across your practice.

Identifying the critical operation points to address when instituting a biosimilar.

Learn about the important considerations for informatics and education when implementing a biosimilar in your health system.

Identify monitoring considerations upon implementation of a biosimilar into your system.